Objective: Epidemiological studies indicate that higher bone mass is associated with moderate alcohol consumption in postmenopausal women. However, the underlying cellular mechanisms responsible for the putative beneficial effects of alcohol on bone are unknown. Excessive bone turnover, combined with an imbalance whereby bone resorption exceeds bone formation, is the principal cause of postmenopausal bone loss. This study investigated the hypothesis that moderate alcohol intake attenuates bone turnover after menopause.
P ostmenopausal women comprise 80% of patients with osteoporosis. 1 Postmenopausal bone loss occurs because of elevated and unbalanced bone turnover, in which bone resorption predominates over bone formation. 2<4 Although osteoporosis is characterized by low bone mass and deterioration of bone microarchitecture, 5 the elevated turnover after menopause is an independent risk factor for osteoporotic bone fractures. 2, 3 Pharmacological interventions that reduce bone turnover are commonly used for the treatment of postmenopausal bone loss. 6 However, high cost and the significant potential for adverse effects contraindicate universal preventive drug therapy. 7 It is therefore important to identify modifiable lifestyle factors that influence the risk of osteoporosis.
Alcohol consumption is a lifestyle factor that has contextdependent effects on the skeleton. Chronic alcohol abuse is associated with reductions in bone mineral density (BMD), 8, 9 osteoblast number, 10<12 and osteoblast function. 8 In contrast, moderate alcohol intake (0.5-2 standard drinks/d) is associated with increased BMD. 13<19 It is uncertain, however, whether the difference in BMD in moderate alcohol consumers is caused by alcohol intake or potential confounding variables.
Carefully controlled animal studies suggest that moderate alcohol consumption decreases bone turnover while maintaining the balance between bone formation and bone resorption. 20 The purpose of the present study was to assess the effects of regular moderate alcohol consumption on bone turnover in healthy early postmenopausal women. An intervention trial conducted for a 15-day period evaluated the effects of alcohol withdrawal and readministration on biochemical markers of bone formation and bone resorption. The working hypothesis was that alcohol withdrawal would result in increased bone turnover markers and that subsequent return to normal alcohol consumption would decrease the turnover markers.
METHODS

Study participants
The study protocol was approved by the Institutional Review Board at Oregon State University, and a written informed consent form was obtained from each participant. The eligibility criteria for the participants were as follows: (1) postmenopausal for 10 years or less; (2) younger than 65 years; (3) not taking hormone therapy (HT) within 6 months of study initiation; and (4) consumption of 0.5 to 2 standard drinks/day (8-28 g of ethanol) in the year before study initiation. Participants were disqualified from the study if they were taking any medication known to affect bone turnover, have had an osteoporosis-related fracture, or had a BMD T score of j2.5 or lower at the femoral neck or spine. 21 Forty-four postmenopausal women consented to participate in this study. Forty completed the study; three of the participants did not meet the entrance criteria, and one participant withdrew before study initiation for reasons unrelated to the study.
Experimental design
The intervention trial, performed over a 15-day time interval, assessed the effects of alcohol withdrawal (days 0-14) and readministration (days 14 to 15) on biochemical markers of bone turnover. The experimental design was based on animal studies demonstrating that alcohol has rapid but reversible effects on bone metabolism. 22 During the week before the intervention, participants maintained their normal alcohol intake and kept a daily record of alcohol consumed. Blood samples were collected at the beginning of the intervention (day 0). During the next 14 days, participants abstained from consuming alcohol, and blood samples were collected on the final day of abstinence (day 14). Participants were then given a container with a predetermined amount of alcohol as a preferred beverage, equivalent to their prior average daily intake. That evening (day 14), participants consumed the alcoholic beverage as part of their normal routine, and blood was collected on the following morning (day 15). To minimize diurnal variation in biochemical markers of bone turnover, 23<26 we collected blood samples from the participants between 7:00 and 9:00 AM. Participants fasted for at least 10 hours before blood collection. Blood samples were centrifuged within 2 hours of collection, and serum was stored frozen at j20-C until analysis.
BMD and body composition
Dual-energy x-ray absorptiometry (DXA; Hologic QDR-4500 Elite A; Hologic, Inc., Waltham, MA) was used to measure whole-body composition (bone, lean mass, and fat mass) and the areal BMD of the proximal femur (total hip, femoral neck, and greater trochanter) and the lumbar spine (L1-L4). Body mass index (BMI) was calculated from DXA-determined body mass and self-reported height. All scans were performed at Oregon State University and analyzed using Hologic software, version 9.80 D (Hologic, Inc.). Quality control was maintained using a bone phantom. The coefficient of variation for repeated DXA scans for hip and lumbar spine BMD in our laboratory is 1.0%.
Alcohol records
During the week before study initiation, participants kept a written record of alcoholic beverages consumed. The type and quantity of alcoholic beverage, as well as the time of day the alcoholic beverage was consumed, were recorded. Average daily alcohol consumption was determined according to the 2010 US Department of Agriculture Dietary Guidelines for typical serving sizes.
Dietary analysis
Before the initiation of intervention, the study participants completed the Block Food Frequency Questionnaire (NutritionQuest, Berkeley, CA). Intake levels of calcium and vitamin D, two dietary factors that are especially important in bone metabolism, were obtained from the questionnaires. Participants submitted their Block Food Frequency Questionnaire and alcohol records at the initial blood draw (day 0).
Serum assays
Serum samples were analyzed for the resorption marker C-terminal telopeptide (CTx) and for the formation marker osteocalcin using enzyme-linked immunosorbent assay (Immunodiagnostics Systems, Scottsdale, AZ). In addition, serum estradiol levels were measured using an enzyme-linked immunosorbent assay (Calbiotech, Spring Valley, CA). All samples for each participant were analyzed using the same assay to eliminate interassay variation. All specimens were assayed in duplicate to reduce the impact of intra-assay variation and to improve precision. The intra-assay variation is 1.7% to 3.0% for CTx, 1.2% to 3.3% for osteocalcin, and 5.7% to 8.6% for estradiol.
Statistical analysis
A simple linear regression model was used to assess the relationship between alcohol intake and BMD, osteocalcin, and CTx at baseline. F tests did not support the adjustment of the primary predictor (alcohol) for age and BMI (P = 0.18 for total hip BMD; P = 0.09 for trochanter BMD; P = 0.40 for femoral neck BMD; and P = 0.74 for lumbar spine BMD). The correlation between serum osteocalcin and CTx was evaluated by linear regression using log-transformed data. During the intervention portion of the study, participants acted as their own controls, and the percentages of changes compared with baseline values (day 0) and abstinence values (day 14) were calculated. Differencing was selected for our data analysis in part because it induced independence without requiring a model that is conditional on the strict assumptions of a parametric normal random-effects distribution and equal variance over time. To determine whether osteocalcin and CTx increased after abstinence from alcohol as predicted, we performed a one-sided paired t test. One-sided paired t tests were also used to determine if osteocalcin and CTx decreased on day 15 as predicted after participants consumed alcohol on the evening of day 14. F tests did not support adjustment for age and BMI for the one-sample model (P = 0.22 for baseline to day 14 serum osteocalcin; P = 0.24 for days 14 to 15 serum osteocalcin; P = 0.10 for baseline to day 14 of serum CTx; and P = 0.56 for days 14 to 15 serum CTx). The assumption of normality for t tests and linear regression performed on original and log-transformed data was assessed using the AndersonDarling test and normal quantile plots. Neither indicated evidence of data departure from normality. All statistical analyses were performed using S + version 8.0 (TIBCO Spotfire, Somerville, MA). Differences were considered significant at P e 0.05. Data are reported as mean T SE.
RESULTS
Study population
The physical characteristics of the study population at baseline are presented in Table 1 and reflect a typical healthy population of postmenopausal women. Based on the Block Food Frequency Questionnaire, the mean daily intakes of calcium were 814 T 46 mg/day as dietary calcium and 748 T 76 mg/day as supplemental calcium, and the mean daily intakes of vitamin D were 128 T 12 IU/day as dietary vitamin D and 383 T 41 IU/day as supplemental vitamin D.
Alcohol intake
Based on 1-week alcohol records before study initiation, the amount of alcohol consumed by the participants averaged 1.4 standard (American) drinks/day or ethanol at 19 T 1 g/day.
BMD
T scores (comparison to young adults) for BMD ranged from j0.50 to j1.00, whereas Z scores (comparison to same age adults) ranged from 0.12 to 0.29 (Table 2) .
Alcohol consumption and BMD
There was a positive association at baseline between alcohol consumption and total hip BMD (Fig. 1A) and between alcohol consumption and trochanter BMD (Fig. 1B) . Significant associations were not detected between alcohol intake and BMD at the femoral neck (Fig. 1C) or the lumbar spine (Fig. 1D) . Femur measurements were not available for one participant owing to a double hip replacement.
Alcohol consumption and biomarkers of bone turnover
A significant linear association between osteocalcin and CTx was observed at baseline (r 2 = 0.36; P G 0.01). However, no relationship between baseline levels of alcohol consumption and bone turnover markers was noted.
Serum osteocalcin and CTx increased after 14 days of abstinence (P = 0.01 and P = 0.02, respectively; Fig. 2 ). When alcohol was administered on the evening of day 14 and when blood was drawn on the morning of day 15, serum osteocalcin and CTx decreased compared with day 14 (P = 0.01 and P = 0.05, respectively). Day 15 levels of serum osteocalcin and CTx did not differ from baseline (P = 0.94 and P = 0.57, respectively).
Alcohol consumption and serum estradiol
Serum estradiol was evaluated in 39 of 40 participants. When all values were included in the calculation of mean T SE, estradiol levels were found to be 7.0 T 1.0 pg/mL on day 0, 7.2 T 1.1 pg/mL on day 14, and 6.6 T 1.2 pg/mL on day 15. However, 33 of 117 samples (each participant assayed at three time points) were below the reliable detection limit for the assay (4 pg/mL). A preliminary analysis set to 0 all values that fell below the detection limit and fitted a general linear model with a compound symmetric correlation structure using maximum likelihood methods. The null hypothesis of equal mean estradiol levels at baseline, day 14, and day 15 had a likelihood ratio of P = 0.67. There also was no evidence of a difference in mean estradiol levels over time when all nonmeasurable levels were set equal to 4 (likelihood ratio P = 0.65). In addition, a linear mixed model was fitted using clustered normal data, with undetectable values treated as intervals censored between 0 and 4. There was no evidence of a difference in the mean estradiol levels from days 0 to 14 (P = 0.52) or between days 14 and 15 (P = 0.40). The very low serum estradiol levels observed in this study are consistent with the expected low levels of estradiol (0-30 pg/mL) in postmenopausal women who are not on HT.
DISCUSSION
This study examined the effects of alcohol withdrawal and subsequent acute restoration of alcohol intake on bone turnover markers in healthy early postmenopausal women. There was a significant increase in the bone turnover markers osteocalcin and CTx when alcohol was excluded for 14 days from the diets of participants who regularly consumed ethanol at 8 to 28 g/day. Within 12 to 14 hours of resuming alcohol consumption, osteocalcin and CTx returned to values that did not differ from baseline (preabstinence levels). Serum estradiol levels were low in all participants, and significant differences in the serum levels of this hormone were not detected with treatment.
Moderate alcohol consumption has no universally accepted definition. Indeed, the quantities of ethanol in a standard drink vary by country and range from 8 to 19.8 g. 27, 28 In the United States, a standard drink contains 13.7 g of ethanol. A metaanalysis of all-cause mortality demonstrated a J-shaped association between alcohol consumption and total mortality. 29 The lowest mortality risk for women was between 1 and 2 drinks/ day. Therefore, the 2 standard drinks/day used in this study is a reasonable upper limit for moderate alcohol consumption.
In the current study, alcohol consumption at baseline was positively associated with BMD at the total hip and at the trochanter, findings similar to those described in much larger cohorts of postmenopausal women in the Epidémiologie de l'Ostéoporose and Framingham studies. 15, 30 Although our intervention study did not detect a significant effect on vertebrae, much larger observational studies investigating postmenopausal women report a beneficial effect of moderate alcohol intake on lumbar spine BMD. 14, 17, 18 Thus, an increased bone mass at one or more sites is consistently associated with moderate drinking in postmenopausal women. 
FIG. 2.
Mean percentage change in serum osteocalcin (A), a marker of bone formation, and in serum CTx (B), a marker of bone resorption, after 14 days of abstinence from alcohol and subsequent restoration of alcohol intake to preabstinence levels. Please note that a relatively brief interval of abstinence (14 d) resulted in significant increases in serum osteocalcin and CTx, whereas resumption of alcohol consumption resulted in an overnight decrease in serum osteocalcin and CTx to levels that did not differ from baseline (day 0). Values are expressed as mean T SE (n = 40 for each time interval). a P e 0.05 versus day 0.
b P e 0.05 versus day 14. CTx, C-terminal telopeptide.
We are not aware of prior intervention studies that investigated the direct effects of alcohol consumption on bone turnover in postmenopausal women. In a cross-sectional study, Rapuri et al 18 reported an association between moderate alcohol intake and decreased bone turnover (lower serum osteocalcin and urinary N-telopeptide of type I collagen) in older, postmenopausal, moderate alcohol consumers. Serum bone turnover markers in postmenopausal women reflect the overall rate of bone remodeling. Bone remodeling involves a highly integrated ongoing process whereby packets of bone are resorbed and replaced. Bone remodeling is initiated by bone resorption and completed by refilling the resorption cavity with new bone. The entire process requires~4 months. 31 Thus, abstinence for much longer than the 14-day interval used in the present study would be required to gauge the full effect of alcohol consumption on bone turnover. Nevertheless, the small but significant increases in osteocalcin and CTx after short-term abstinence provide substantial evidence that moderate alcohol consumption decreases bone turnover.
A dose response between alcohol intake and markers of bone turnover was not detected in the current study, but the study was inadequately powered to detect such changes. Also, the short duration of intervention and the relatively narrow range of alcohol consumed were limiting factors in evaluating dose-dependent effects. However, our results in postmenopausal women are consistent with a dose-response study investigating the effects of alcohol on bone turnover in an animal model. Groups of rats fed alcohol comparable to moderate drinkers (3% and 6% of total energy intake) had balanced reductions in osteoclast and osteoblast numbers. 20 In contrast, consumption of higher levels of alcohol by rats resulted in further reductions in bone formation with a net increase in bone resorption and subsequent bone loss. 20 In the current study, we observed a reduction in bone turnover markers 12 to 14 hours after a single administration of alcohol to values that did not differ significantly from baseline. Acute effects of alcohol were also observed in a recent study by Sripanyakorn et al, 32 which evaluated bone turnover markers in a cohort of adult (20-47 y) healthy men and women. Using the participants as their own controls, a significant reduction in serum CTx was observed within 6 hours of ingestion of beer containing 28 g of alcohol. Thus, both studies support the conclusion that amounts of alcohol likely to be consumed in the diet result in rapid reductions in biomarkers of bone resorption. In contrast to the current study, changes in bone formation markers in response to alcohol were not observed by Sripanyakorn et al. 32 The failure of Sripanyakorn et al 32 to detect an inhibitory effect of alcohol on bone formation may have been caused by differences in experimental design. In addition to the differences already noted, Sripanyakorn et al 32 performed a time-course (1-6 h after alcohol administration) analysis of blood bone turnover biomarkers in a clinical setting, whereas we performed measurements 12 to 14 hours after alcohol consumption in free-living participants. Alternatively, there may be important age and/or sex differences in the skeletal response to moderate alcohol intake.
We should note several limitations in this study. First, this was not a randomized clinical trial. Second, eligibility based on study criteria, with the exception of BMD and HT requirements, was self-reported by the participants. Third, all but one of the 40 participants were white. Therefore, the homogeneity of the sample with regard to ethnicity limits the generalizability of the study findings. Fourth, the study is likely to underestimate the effect of alcohol on bone turnover markers because the residual effects of prior long-term alcohol use on bone remodeling would be expected to persist for more than 14 days. Fifth, the study probably underestimates the acute effects of alcohol because sampling was performed at a single fixed interval after alcohol consumption. Sixth, although most of the women were wine drinkers, the type of drink consumed was not controlled for. As such, the possibility that nonalcoholic components of drinks influenced bone metabolism cannot be excluded. However, we and others have clearly demonstrated profound skeletal effects of ethanol. In spite of these limitations, this study demonstrates that moderate alcohol intake has rapid suppressive effects on bone turnover markers in postmenopausal women.
Moderate alcohol consumption, although associated with a lower risk of cardiovascular disease, cardiovascular diseaseY related mortality, and all-cause mortality, may increase the risk for breast cancer. 33, 34 An increase in aromatase activity has been suggested as a mechanism for the effects of alcohol on estrogen target cells. 35 However, in the present study, we detected no change in serum estradiol levels. Although there is substantial evidence that moderate alcohol consumption correlates with higher BMD in postmenopausal women, it is much less clear whether consuming alcohol lowers the fracture rate. Therefore, even if drinking had no detrimental effects, it would be unwise to recommend drinking for the purpose of preventing fractures. On the other hand, according to World Health Organization data, the per-capita yearly consumption of alcohol for adults (15+ y) in industrialized countries ranges from 8 to 16 L/year and, at least for the United States, has not changed markedly (other than during the Prohibition Era) for the last 100 years. In our study population of postmenopausal moderate drinkers, alcohol contributed an estimated 4% to 12% of total energy. Thus, many women drink regularly, and most of these drinkers do not abuse alcohol. It is therefore important to understand the physiological impact of alcohol as a major, highly bioactive component of the diet.
CONCLUSIONS
In summary, we show that a relatively short interval of abstinence from moderate alcohol consumption by early postmenopausal women results in increased serum levels of the biochemical markers of bone formation and bone resorption and that subsequent resumption of alcohol intake in the diet rapidly reduces the levels of these markers. Thus, our findings support the hypothesis that moderate dietary alcohol consumption may slow bone loss in postmenopausal women by attenuating increased bone turnover. The observed actions provide a plausible cellular mechanism for the positive association between moderate alcohol consumption and BMD observed in postmenopausal women. Further studies are required to determine if moderate dietary alcohol consumption, in addition to lowering biochemical markers of bone turnover, alters the negative bone remodeling balance in postmenopausal women.
